Vectors Research Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$4.91M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.82M |
| 3 |
Broadstone Net Lease
BNL
|
+$2.66M |
| 4 |
Invesco Variable Rate Investment Grade ETF
VRIG
|
+$2.55M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$2.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$2.64M |
| 2 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$2.33M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.05M |
| 4 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$918K |
| 5 |
Lockheed Martin
LMT
|
+$840K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.71% |
| 2 | Financials | 5.39% |
| 3 | Healthcare | 4.77% |
| 4 | Consumer Staples | 3.78% |
| 5 | Consumer Discretionary | 3.25% |
Similar funds
Vectors Research Management's Q1 2021 Portfolio in Review
As of Q1 2021, Vectors Research Management held 493 positions worth $363M, up 12% from $325M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Vectors Research Management deployed $23.3M of net new capital in Q1 2021, opening 45 new positions and adding to 101 existing holdings. Its largest new stake was Broadstone Net Lease: 144,224 shares worth $2.64M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $2.64M trimmed.
- Vectors Research Management's largest Q1 2021 buy was Broadstone Net Lease: 144,224 shares worth $2.64M.
- Vectors Research Management added most to iShares Floating Rate Bond ETF in Q1 2021, an estimated $4.91M increase.
- Vectors Research Management's biggest Q1 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $2.64M.
- Vectors Research Management fully exited Arena Pharmaceuticals Inc in Q1 2021, selling an estimated $282K.
- Vectors Research Management's ten largest holdings make up 38% of its $363M portfolio in Q1 2021.
- Vectors Research Management opened 45 new positions and closed 47 in Q1 2021.
- Vectors Research Management's portfolio value rose 12% quarter-over-quarter to $363M.
Based on Vectors Research Management's 13F filing for Q1 2021, filed 18 May 2021.